Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
Song GY, Kim T, Ahn SY, Jung SH, Kim M, Yang DH, Lee JJ, Choi SH, Kim MY, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Park SK, Kim SH, Zhang Z, Ahn JS, Kim HJ, Kim DDH.
Song GY, et al. Among authors: kim ddh, kim hj, kim t, kim sh, kim m, kim my.
Bone Marrow Transplant. 2022 Dec;57(12):1810-1819. doi: 10.1038/s41409-022-01817-0. Epub 2022 Sep 23.
Bone Marrow Transplant. 2022.
PMID: 36151367